Andrew M. Evens

Rutgers, The State University of New Jersey

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 21 papers. Top paper: “Pembrolizumab followed by AVD in untreated early unfavorable and advanced-stage classical Hodgkin lymphoma”.

Pembrolizumab followed by AVD in untreated early unfavorable and advanced-stage classical Hodgkin lymphoma

Blood(2020)10.1182/blood.2020007400

N/A

4.5DataRank · unranked

141 citations

Hatice Savas, Andrew M. Evens, Ranjana H. Advani, Brett Alan Palmer, Barbara Pro +11 more

Nivolumab+AVD in Advanced-Stage Classic Hodgkin’s Lymphoma

New England Journal of Medicine(2024)10.1056/nejmoa2405888

N/A

3.4DataRank · unranked

211 citations

Michael LeBlanc, Sharon M. Castellino, Hongli Li, Sarah C. Rutherford, Andrew M. Evens +42 more

A Three-Arm Randomized Phase II Study of Bendamustine/Rituximab with Bortezomib Induction or Lenalidomide Continuation in Untreated Follicular Lymphoma: ECOG-ACRIN E2408

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-1345

N/A

0.851DataRank · unranked

22 citations

Fangxin Hong, Thomas M. Habermann, Ranjana H. Advani, Randy D. Gascoyne, Thomas E. Witzig +11 more

Outcomes of Burkitt lymphoma with central nervous system involvement: evidence from a large multicenter cohort study

Haematologica(2021)10.3324/haematol.2020.270876

N/A

0DataRank · unranked

42 citations

Andrew M. Evens, Alexey V. Danilov, Stephen D. Smith, Deepa Jagadeesh, Lori A. Leslie +52 more

Development and validation of a prediction model for 1-year mortality among older adults with Hodgkin Lymphoma who receive dose-intense chemotherapy

Journal of Geriatric Oncology(2021)10.1016/j.jgo.2021.07.003

N/A

0DataRank · unranked

16 citations

Jason Nelson, Angie Mae Rodday, Andrew M. Evens, Jonathan W. Friedberg, Tanya M. Wildes +2 more

Scaffold-mediated switching of lymphoma metabolism in culture

Cancer & Metabolism(2022)10.1186/s40170-022-00291-y

N/A

0DataRank · unranked

7 citations

Dashnamoorthy Ravi, Andrew M. Evens, Biju Parekkadan, Rachana Bhatt

COVID-19 perceptions, impacts, and experiences: a cross-sectional analysis among New Jersey cancer survivors

Journal of Cancer Survivorship(2022)10.1007/s11764-022-01236-6

N/A

0DataRank · unranked

4 citations

Angela J. Fong, Nabarun Ghosh, Katie A. Devine, Denalee O’Malley, Lisa E. Paddock +5 more

An Analysis of Transcriptomic Burden Identifies Biological Progression Roadmaps for Hematological Malignancies and Solid Tumors

Biomedicines(2022)10.3390/biomedicines10112720

N/A

0DataRank · unranked

3 citations

Afshin Beheshti, Kristine Burgess, Athena Kritharis, Ying Chen, Andrew M. Evens +2 more

NIVOLUMAB(N)‐AVD IMPROVES PROGRESSION‐FREE SURVIVAL COMPARED TO BRENTUXIMAB VEDOTIN(BV)‐AVD IN ADVANCED STAGE (AS) CLASSIC HODGKIN LYMPHOMA (HL): RESULTS OF SWOG S1826

Hematological Oncology(2023)10.1002/hon.3163_5

N/A

0DataRank · unranked

21 citations

Michael LeBlanc, Sharon M. Castellino, Huilin Li, Sarah C. Rutherford, Andrew M. Evens +41 more

The impact of classic Hodgkin lymphoma on informal caregivers: results from the CONNECT cross-sectional survey

Supportive Care in Cancer(2023)10.1007/s00520-023-08120-8

N/A

0DataRank · unranked

2 citations

Andrew M. Evens, Nicholas Liu, Kristina S. Yu, Rachel Byrd, Michelle A. Fanale +5 more

Impact of Preexisting Heart Failure on Treatment and Outcomes in Older Patients With Hodgkin Lymphoma

JACC CardioOncology(2024)10.1016/j.jaccao.2024.02.003

N/A

0DataRank · unranked

14 citations

Jason Nelson, Benjamin Sweigart, Angie Mae Rodday, Anita J. Kumar, Marvin A. Konstam +8 more

Identification of genetic subtypes in follicular lymphoma

Blood Cancer Journal(2024)10.1038/s41408-024-01111-w

N/A

0DataRank · unranked

13 citations

Rajesh Detroja, Ting Liu, Keren Isaev, Anjali Silva, Verena Passerini +28 more

Characterizing influence of rCHOP treatment on diffuse large B-cell lymphoma microenvironment through in vitro microfluidic spheroid model

Cell Death and Disease(2024)10.1038/s41419-023-06299-6

N/A

0DataRank · unranked

6 citations

Rachel P. White, Dashnamoorthy Ravi, Ninad S. Kanetkar, Ilana Berger Fridman, Adam K. Ekenseair +3 more

Deciphering the Metabolic Basis and Molecular Circuitry of the Warburg Paradox in Lymphoma

Cancers(2024)10.3390/cancers16213606

N/A

0DataRank · unranked

1 citations

Athena Kritharis, Andrew M. Evens, Dashnamoorthy Ravi

21 | PROGNOSTIC VALUE OF CIRCULATING TUMOR DNA IN PATIENTS WITH ADVANCED STAGE CLASSIC HODGKIN LYMPHOMA TREATED ON SWOG S1826

Hematological Oncology(2025)10.1002/hon.70093_21

N/A

0DataRank · unranked

4 citations

Marcin Kaszkowiak, Michael LeBlanc, Chip Stewart, Alex F. Herrera, J Castillo +18 more

20 | IMPACT OF EBV STATUS AND HISTOLOGY ON OUTCOMES WITH NIVOLUMAB‐AVD VERSUS Bv‐AVD IN PATIENTS ENROLLED ON SWOG S1826

Hematological Oncology(2025)10.1002/hon.70093_20

N/A

0DataRank · unranked

1 citations

H. Li, Alex F. Herrera, Anamarija M. Perry, Alexandra E. Kovach, Kelly Davison +13 more

127 | HEALTH‐RELATED QUALITY OF LIFE (HRQoL) ENDPOINTS OF THE PHASE III INTERGROUP S1826 ADVANCED‐STAGE, CLASSIC HODGKIN LYMPHOMA (cHL) TRIAL

Hematological Oncology(2025)10.1002/hon.70093_127

N/A

0DataRank · unranked

1 citations

H. Li, Alex F. Herrera, Kelly Davison, Sharon M. Castellino, Hildy Dillon +11 more

Prognostic impact of extranodal disease on PET/CT in follicular lymphoma: results from a validation study with ECOG 2408

Blood Neoplasia(2025)10.1016/j.bneo.2025.100113

N/A

0DataRank · unranked

1 citations

Stephen M. Broski, Zequn Sun, Masha Kocherginsky, Betsy LaPlant, Matthew J. Maurer +10 more

126 | THE EARLY‐STAGE CLASSIC HODGKIN LYMPHOMA INTERNATIONAL PROGNOSTICATION INDEX (E‐HIPI): AN INDIVIDUALIZED PREDICTION MODEL UTILIZING OBJECTIVE AND CONTINUOUS VARIABLES

Hematological Oncology(2025)10.1002/hon.70093_126

N/A

0DataRank · unranked

0 citations

Angie May Rodday, Matthew J. Maurer, Jenica Upshaw, Nicholas Counsell, Sabrina Rossetti +19 more

Genetic heterogeneity of diffuse large B-cell lymphoma

UNC Libraries(2020)10.17615/dkye-0q87

N/A

0DataRank · unranked

23 citations

Gopesh Srivastava, Leon Bernal‐Mizrachi, Eric D. Hsi, Katherine Walsh, Magdalena Czader +27 more

The Genetic Basis of Hepatosplenic T-cell Lymphoma

UNC Libraries(2020)10.17615/vdkf-4m21

N/A

0DataRank · unranked

0 citations

Wing C. Chan, Steven M. Horwitz, Eric D. Hsi, Anupama Reddy, Nicholas S. Davis +50 more